Cargando…
Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487865/ https://www.ncbi.nlm.nih.gov/pubmed/28523624 http://dx.doi.org/10.1007/s12325-017-0543-6 |
_version_ | 1783246535583072256 |
---|---|
author | Hunt, Barnaby Mocarski, Michelle Valentine, William J. Langer, Jakob |
author_facet | Hunt, Barnaby Mocarski, Michelle Valentine, William J. Langer, Jakob |
author_sort | Hunt, Barnaby |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5487865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-54878652017-07-03 Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA Hunt, Barnaby Mocarski, Michelle Valentine, William J. Langer, Jakob Adv Ther Erratum Springer Healthcare 2017-05-18 2017 /pmc/articles/PMC5487865/ /pubmed/28523624 http://dx.doi.org/10.1007/s12325-017-0543-6 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Erratum Hunt, Barnaby Mocarski, Michelle Valentine, William J. Langer, Jakob Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA |
title | Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA |
title_full | Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA |
title_fullStr | Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA |
title_full_unstemmed | Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA |
title_short | Erratum to: Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA |
title_sort | erratum to: evaluation of the short-term cost-effectiveness of ideglira versus continued up-titration of insulin glargine u100 in patients with type 2 diabetes in the usa |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487865/ https://www.ncbi.nlm.nih.gov/pubmed/28523624 http://dx.doi.org/10.1007/s12325-017-0543-6 |
work_keys_str_mv | AT huntbarnaby erratumtoevaluationoftheshorttermcosteffectivenessofidegliraversuscontinueduptitrationofinsulinglargineu100inpatientswithtype2diabetesintheusa AT mocarskimichelle erratumtoevaluationoftheshorttermcosteffectivenessofidegliraversuscontinueduptitrationofinsulinglargineu100inpatientswithtype2diabetesintheusa AT valentinewilliamj erratumtoevaluationoftheshorttermcosteffectivenessofidegliraversuscontinueduptitrationofinsulinglargineu100inpatientswithtype2diabetesintheusa AT langerjakob erratumtoevaluationoftheshorttermcosteffectivenessofidegliraversuscontinueduptitrationofinsulinglargineu100inpatientswithtype2diabetesintheusa |